Cancer cells often exhibit loss of functional tight junctions (TJs), and disruption of the TJ structure is associated with cancer development. However, whether loss of a certain type of claudin, an integral membrane protein of TJs, is involved in malignant phenotypes remains to be clarified. Based on the report that claudin-6 functions as a tumor suppressor for breast cancer, we show here that suppression of claudin-6 expression results in increased resistance to various apoptogens, and causally enhances anchorage-independent growth properties.
Introduction
Tight junctions (TJs) are intercellular structures in epithelial and endothelial cells, primarily playing a critical role in cell-cell adhesion. (1, 2) Recent evidence has revealed that TJs are directly involved in the regulation of cellular functions such as proliferation, differentiation, and apoptosis, due to the ability of TJ proteins to recruit various signaling molecules that have proliferative and differentiative capacities, including transcription factors, lipid phosphatases, and cell cycle regulators. (1) (2) (3) While one of the first identified TJassociated molecules was occludin, (4, 5) claudins, of which there are at least 24, have been shown to be the main constituents as integral membrane proteins of TJs. (1, 2) A growing body of evidence has demonstrated that cancer cells, particularly in those tumors that manifest high metastatic potential, often exhibit loss of functional TJs. (6) Disruption of the TJ structure has been shown to be associated with cancer development, which may be causally involved in malignant phenotypes such as local tumor growth, invasion, and metastasis at distant sites. (6) (7) (8) We have also demonstrated that epigenetic silencing of occludin contributes to enhanced tumorigenicity of cancer cells. (9, 10) In parallel, decreased and/or impaired TJ formation has been reported for various types of cancer, and genes having an oncogenic character are known to disrupt TJs. (11, 12) In addition, a number of immunohistochemical studies showed reduced expression of claudins in a variety of cancer tissues. (11, 13, 14) Many members of the claudin family show a distinct organ-specific distribution of such expression and are abnormally regulated in several human cancers;
however, the functional roles of claudins in cancer cells have not been clearly defined.
Based on the finding that claudin-6 is preferentially expressed in mammary epithelial cells and functions as a tumor suppressor for breast cancer, (15) we examined whether loss of 4 claudin-6 had any effect on MCF7 breast carcinoma cells. Herein, we clearly show that the knockdown of endogenous claudin-6 in MCF7 cells resulted in increased resistance to a number of differently acting apoptogens, and causally enhanced anchorage-independent growth. These findings support our plausible hypothesis that the decreased expression of claudin-6 may at least partially contribute to enhanced tumorigenicity of breast carcinoma cells.
Materials and Methods
Cell line and transfection. MCF7, a human breast carcinoma cell line, was maintained in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (Sanko Jyunyaku, Tokyo, Japan), 10 mM HEPES, 100 U/ml penicillin, and 100 g/ml streptomycin. Claudin-6-specific small interfering RNA (siRNA, 10 nM as a default concentration in the dose range of 10-100 nM; QIAGEN, Tokyo, Japan) was transfected into the cells 48 h before apoptotic stimulation, using FuGENE 6 (Roche, Indianapolis, IN). Negative control siRNA (Santa Cruz Biotechnologies, Santa Cruz, CA) was also transfected. siRNA-mediated suppression of claudin-6 expression was confirmed by quantitative reverse transcription (RT)-PCR and western blot analysis.
Cell death analyses. Apoptosis was stimulated with oxidative stress using H 2 O 2 (Sigma, Tokyo, Japan) in the dose range from 0 to 100 M with cells treated for 1 h to 24 h, and various death-inducing agents, including heat shock at 42C for 30 min, etoposide (50 M), cisplatin (10 g/ml), and -irradiation (100 Gy). Anoikis was induced by preventing cells from adhering to the cell culture dishes. (9) In some experiments, cells were transfected with or without claudin-6-specific siRNA in the presence or absence of all-trans retinoic acid (atRA, 100 nM, Sigma), which is an apoptotic sensitizer. (16) To examine the effect of a demethylating agent, the cells were treated with 5'-aza-2'deoxycytidine (5'Aza-dC, 1 M as a default concentration in the dose range from 0-5 M, Sigma) for 48 h, after which a histone deacetylase inhibitor (HDAI) or trichostatin A (TSA, 100 nM as a default concentration in the dose range from 0-300 nM, Sigma) was added, followed by incubation for an additional 24 h at 37C. Apoptotic cell death was evaluated as described. (9, 16) Briefly, total cells in the 6 tissue culture wells were harvested, and resuspended in lysis buffer containing 10 mM TrisHCl (pH 8.0), 10 mM EDTA, and 0.5% Triton X-100 for 15 min at 4C. The cells were then centrifuged at 12,000 xg for 20 min at 4C to separate intact chromatin in the pellet from DNA fragments in the supernatant that preferentially contained low molecular weight cellular DNA. (9) The DNA amounts in each pellet and supernatant were determined using a diphenylamine reagent and the fragmentation rate (%) was expressed as (fragmented DNA / total DNA) x 100. DNA samples were also electrophoresed on 2.5% agarose gels to show the ladder formation due to nuclear fragmentation. To confirm the quantitativeness of cell death, we also performed the terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) assay using an In Situ Cell Death Detection Kit (Roche). The positive cells were scored using light microscopy by counting the number of cells under low magnification (x 100) in 10 separate arbitrarily selected fields in each section. Invasive cells were measured after 48 h incubation at 37°C. The bottom surface of the top chamber was wiped with cotton swabs, and cells that passed through the filters into the lower surface of the well were quantitated. Similarly, transmigration assay through a rat lung endothelial cell (RLE) monolayer was done as described. (17) Transmigrated viable cells on the lower surface of the transwell (8 m pores) were quantitated after harvesting the cancer cells on the endothelial monolayer for 24 h. Statistical analysis. Unless otherwise specified, all data represent the mean  SD of at least 3 independent experiments, each in triplicate wells. Statistical differences were analyzed using the paired t test, and were considered statistically significant when p<0.05.
Results
Claudin-6 expression is partially suppressed by CpG island hypermethylation. Aberrant promoter region CpG island hypermethylation is associated with transcriptional silencing of many genes in a wide variety of cancers. (19) Our previous studies have demonstrated that the synergistic effect of a demethylator (5'Aza-dC) and HDAI (TSA) upregulates the expression of endogenous occludin, which eventually enhances the apoptotic sensitivity to various apoptogens. (9, 10) Therefore, we first examined whether treatment with the demethylator and HDAI altered the expression of other TJ-associated genes. We found that treatment with 5'Aza-dC and TSA could induce upregulation of a number of TJ-associated genes such as those of occludin, claudin-1, -2, and -6 (Fig. 1a) . The most striking effect by these agents was observed in the gene-expression alterations in claudin-6, in which claudin-6 mRNA was increased approximately 3-fold by treatment with 5'Aza-dC alone and 5-fold by the synergistic effect with 5'Aza-dC and TSA (Fig. 1b) . These agents did not change the expression of claudin-3, -4, or -7 (Fig. 1a) , and the expression of claudin-5 and -8 was not observed in MCF7 cells (data not shown). These findings suggested that claudin-6 expression was preferentially suppressed by CpG island hypermethylation in MCF7 cells.
According to a search of a genome database, CpG islands exist in the promoter region of human claudin-6. We then performed MSP analysis of MCF7 cells and found that CpG islands in the claudin-6 promoter were strongly methylated (Fig. 1c) . However, MCF7 cells were partially unmethylated in this region (Fig. 1c ) and, as a result, an appreciable amount of endogenous claudin-6 expression was detected (Fig. 1a, 2a ).
Decreased expression of claudin-6 provides apoptotic resistance in MCF7 cells. It has been documented that claudin-6 is preferentially expressed in mammary epithelial cells and that the expression of claudin-6 is decreased in mammary cancer cell lines and breast cancer sample compared to normal breast tissue. (15) We also found that the promoter region of claudin-6 was densely methylated in MCF7 cells (Fig. 1c) . To examine the functional role of claudin-6 in MCF7 cells, we determined the differential sensitivity of apoptosis to 24 h exposure to H 2 O 2 , which is a common cell stressor used to induce apoptosis. (9, 16) Prior to the apoptotic stimulation, the cell medium was changed to one without FBS supplementation and cells were exposed to the apoptogens. Preliminary experiments confirmed that a wide range of concentrations of siRNA could effectively suppress endogenous claudin-6 expression ( Fig.   2a, 2b ). Treatment with atRA clearly enhanced the sensitivity to H 2 O 2 -induced cell death in dose-and time-dependent manners, whereas knockdown of claudin-6 expression provided significant resistance to apoptosis (Fig. 2c ,left panel, and Fig. 2d ). We further employed the TUNEL assay and showed that with decreased expression of claudin-6 the sensitivity to H 2 O 2 -induced cell death was suppressed (Fig. 2c, right panel) , which was coincident with the results of our assay (Fig. 2c, left panel) . On the other hand, manual cell counting every 24 h up to day 6 after plating equal numbers of cells showed no significant differences in the cell proliferation and DNA synthesis rates (Fig. 2e) . We next determined whether the suppressive role due to loss of claudin-6 was applicable to other apoptogenic stimuli, including oxidative stress, heat shock, genotoxic agents, and -irradiation. Decreased expression of claudin-6 also resulted in appreciable inhibition of apoptotic cell death against these stimuli (Fig. 2f) ,
suggesting that the protective role of claudin-6 against apoptosis could be observed following exposure to a broad range of cell stressors. These observations suggested that claudin-6 expression modulated the apoptotic sensitivity of the cells.
We could not examine the function of TJs of MCF7 cells because this cell line did not form a uniformly flat epithelial monolayer sheet on the semipermeable membrane support.
Nor did we observe any morphological alterations in the course of the experiment when claudin-6 expression was induced or suppressed in the MCF7 cells (data not shown).
Decreased expression of claudin-6 inhibits anoikis. Evasion of and resistance to apoptosis are characteristic of cancer, and breakdown of anoikis may be a predominant contributor to oncogenic progression. (20, 21) We therefore examined whether siRNA-mediated knockdown of claudin-6 expression inhibited anoikis in MCF7 cells. DNA fragmentation analysis demonstrated that decreased expression of claudin-6 clearly showed the limited sensitivity to anoikis (Fig. 3a) . TUNEL assay also revealed that atRA increased the sensitivity to anoikis in MCF7 cells, whereas siRNA-mediated knockdown of claudin-6 expression resulted in resistance to anoikis even in the presence of atRA (Fig. 3b) . Suppression of endogenous claudin-6 expression in MCF7 cells provided significant resistance to H 2 O 2 -induced apoptosis and anoikis, causing significant promotion of colony formation in two-and threedimensional cultures (Fig. 3c) . Since claudin-6 siRNA was transfected transiently in this experiment, it was clear that endogenous expression of claudin-6 was increased with cell division. We should note here that MCF7 cells required 24 h for maximum reduction of claudin-6 after being transfected with claudin-6-specific siRNA, and significant suppression of claudin-6 was observed for 5 days (Fig. 3d) . This suggested that the colony formation was primarily determined by the sensitivity to apoptosis within a few days after plating for cell culture, in which significant suppression of claudin-6 expression was observed by siRNA transfection.
Methylator phenotype of claudin-6 promotes anchorage-independent growth. We next examined whether the observed phenotypes induced by 5'Aza-dC/TSA treatment were due to enhanced expression of endogenous claudin-6, because 5-Aza-dC/TSA treatment leads to the derepression of a large number of genes. (18, 19) In MCF7 cells, either 5'Aza-dC alone and a synergistic effect with 5'Aza-dC and TSA was sufficient for apoptotic sensitization (Fig. 4a) and for suppression of colony forming capabilities in two- (Fig. 4b, left panel) and threedimensional cultures (Fig. 4b, right panel) . Importantly, claudin-6-specific siRNA significantly abrogated these effects, being possible to link the induction of endogenous claudin-6 with the observed phenotypes mediated by 5'Aza-dC/TSA. In addition, double knockdown of claudin-6 and occludin had marked effects on apoptosis (Fig. 4a ) and colonyforming efficacy (Fig. 4b) , when compared with the cells transfected only with claudin-6-specific siRNA. (9, 10) Negative control siRNA had no effect on the cells during the course of the experiment (data not shown). These observations suggested that epigenetic silencing of claudin-6 may partially but significantly contribute to enhanced anchorage-independent growth of cancer cells.
Claudin-6 decreases invasiveness and transmigration through endothelial monolayer.
To determine whether claudin-6 expression in cancer cells had a causal role in its invasive and transmigrative properties, we performed a Boyden chamber invasion assay and a transmigration assay through an endothelial monolayer. We found that with decreased expression of claudin-6 invasive and transmigrative capacities of MCF7 cells were significantly increased, when compared with the control cells (Fig. 5a, 5b) . A gelatin zymogram for MMP activation also demonstrated that claudin-6 knockdown resulted in an increase in MMP activity and efficiently abrogated atRA-mediated downregulation of MMP 14 activity (Fig. 5c ). In addition, transfection with claudin-6-specific siRNA increased adhesion to the endothelial cells, which is known to be critical step for cancer cells to form a distant metastasis (Fig. 5d) . These data suggested that loss of claudin-6 expression was potentially associated with the invasive and transmigrative phenotypes of cancer cells.
Discussion
We have demonstrated that the methylator phenotype of occludin favors multiple steps known to be important in tumorigenesis, identifying occludin as a likely tumor suppressor gene in certain types of cancer. (9, 10) Similarly, this study was undertaken to understand the biological significance of altered claudin-6 expression in breast cancer. We found that epigenetic silencing of claudin-6 expression potentially contributed to the highly tumorigenic and invasive properties of MCF7 breast carcinoma cells.
Promoter CpG island hypermethylation is an important means to epigenetically silence a particular gene associated with a carcinogenic step at the transcriptional level. (19) Our results showed that claudin-6 expression was partially but significantly inactivated by Although claudin-4 is, for example, a substrate for EphA2 receptor tyrosine kinase,
other claudins have the potential to be phosphorylated by EphA2 due to structural homology between the TJ-associated molecules. Since EphA2 is frequently overexpressed in a variety of cancers, including breast cancers, and is a direct transcriptional target of the Ras-Rafmitogen-activated protein kinase pathway, (23, 24) it is thus possible that the cellular No direct proof exists to support this possibility, and we cannot presently determine whether claudin-6 has specific effects on the cells when compared with the other types of claudins.
On the other hand, several studies have confirmed the paradoxical upregulation of claudins in various cancers derived from the breast, stomach, pancreas, and ovary. (25, 26) In addition, certain types of claudins have been shown to modify tumor invasion by regulation of MMP activity, suggesting the potential involvement of claudins in invasion and metastasis of cancer cells. (27, 28) Although the functional importance of claudins in cancers has been suggested by a number of studies, future studies should address the underlying mechanisms by which certain TJ proteins determine the progressiveness of cancer cells.
It has been postulated that the formation of TJs reduces the highly tumorigenic phenotype of cancer cells. A number of reports have shown that the overexpression of TJassociated genes confers less tumorigenic and invasive phenotypes in vivo, accompanied by an increase in TJs between cell boundaries in certain claudin-overexpressing cells. (7, 8) These observations lead to the conclusion that TJ protein in cancer cells forms diffusion barriers and restricts the access of nutrients and growth factors inside the cell aggregates, and that an 
